Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel
· Delayed Price · Currency is ILS · Price in ILA 113.00
0.00 (0.00%)
Mar 5, 2026, 1:31 PM IDT
TLV:IMED Revenue
Imed Infinity Medical-Limited Partnership had revenue of $657.00K USD in the half year ending June 30, 2025, a decrease of -215.87%. This brings the company's revenue in the last twelve months to $818.00K, down -265.25% year-over-year. In the year 2024, Imed Infinity Medical-Limited Partnership had annual revenue of $41.00K, down -104.35%.
Revenue (ttm)
$818.00K
Revenue Growth
-265.25%
P/S Ratio
1.65
Revenue / Employee
$11.69K
Employees
70
Market Cap
4.56M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.00K | 983.00K | -104.35% |
| Dec 31, 2023 | -942.00K | -1.14M | -571.00% |
| Dec 31, 2022 | 200.00K | 125.00K | 166.67% |
| Dec 31, 2021 | 75.00K | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Evogene | 26.54M |
| XTL Biopharmaceuticals | 3.26M |
| Can-Fite BioPharma | 1.89M |
| Erika Carmel-Tech | 39.63M |